Connect your AI

Medline, Inc. MDLN Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Henry ScheinHSIC

1M0.0%

UFP TechnologiesUFPT

1M—

ICU MedicalICUI

500K0.0%

IAR

Integra LifeSciencesIART

15M0.0%

CorMedixCRMD

2M0.0%

McKessonMCK

——

Other financials

Income statement

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

Market cap$33.35B+17.5%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medline, Inc. 's convertible preferred stock authorized shares?: Medline, Inc. (MDLN) reported convertible preferred stock authorized shares of 5B in Q1 2026.
What does convertible preferred stock authorized shares mean?: Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.